ZBIO

Zenas BioPharma
ZBIO

Upgrade to unlock
Buy
Hold
Sell

3 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$36
59% upside
High target

3 analyst ratings

positive
1  neutral
33%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
HC Wainwright & Co
HC Wainwright & Co
Matthew Caufield
75% 1-yr ZBIO win rate
10 Feb ‘26 1 month ago
Morgan Stanley
Morgan Stanley
Judah Frommer
0% 1-yr ZBIO win rate
6 Jan ‘26 2 months ago
Wedbush
Wedbush
Martin Fan
67% 1-yr ZBIO win rate
22 Dec ‘25 2 months ago